Congratulations to the LEAP Awards for Test & Measurement winners, who are profiled here: Liquid Instruments’ Moku:Delta is ...

Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...

Bristol-Myers Squibb's flurry of dealmaking has continued with en expansion of its partnership with BridgeBio on drugs targeting SHP2, in the hope of combining them with its cancer immunotherapy ...

Overvoltage/Undervoltage protection (pack and cell level) Overcurrent protection (charging and discharging) Temperature protection (charging, discharging, MOSFET ...